#biotech financing
3 articles
Corporate Finance
Artiva Biotherapeutics faces capital shortfall risk ahead of pivotal NK cell therapy trials
ViaNews Editorial Team (Finance)•
Corporate Finance
Cardiff Oncology Burns Through $12M Per Quarter With 5 Quarters Of Cash Remaining
ViaNews Editorial Team (Finance)•